Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Tengion gets $54mm through its Series C round

Executive Summary

Tengion (regenerative medicine) has raised $33mm through the closing of its Series C venture round. New investor Deerfield Partners was joined by returning backers Bain Capital, J&J Development Corp., HealthCap, Quaker BioVentures, Oak Investment Partners, and L Capital Partners. Tengion's current lenders, Horizon Technology and Oxford Finance, also made equity investments.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies